| 
                                                 
                                                
                                                    | 
                                                        BARICITINIB中间体
                                                     | 
                                                 
                                             
                                        
                                         | 
                                        
                                           
                                            
                                            
                                                
                                                    - CAS号:
 
                                                    - 1187594-13-3
 
                                                 
                                                
                                                    - 英文名:
 
                                                    - 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
 
                                                 
                                                
                                                    - 英文别名:
 
                                                    - Barretinib intermediate 2;1-(Ethylsulfonyl)-3-[4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine;2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile;(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile;2-[1-ethanesulfonyl-3-[4-(7-[(2-(trimethylsilyl)ethoxy)methyl]-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-yl]azetidin-3-yl]acetonitrile;3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]-;2-[1-ethanesulfonyl-3-[4-(7-[(2-(trimethylsilyl)ethoxy)methyl]-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl]acetonitrile;2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
 
                                                 
                                                
                                                    - 中文名:
 
                                                    - BARICITINIB中间体
 
                                                 
                                                
                                                    - 中文别名:
 
                                                    - 巴瑞替尼中间体;巴瑞克替尼杂质29;巴瑞克替尼中间体8;BARICITINIB中间体;2-(1-(乙基磺酰基)-3-(4-(7-((2-(三甲基硅烷基)乙氧基)甲基)-7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-基)氮杂环丁烷-3-基)乙腈;2-(1-(乙基磺酰基)-3-(4-7-((2-(三甲基甲硅烷基)乙氧基)甲基)-7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-基)氮杂环丁烷-3-基)之腈;2-(1-(乙基磺酰基)-3-(4-(7 - ((2-(三甲基甲硅烷基)乙氧基)甲基)-7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-基)氮杂环丁烷-3-基)乙腈
 
                                                 
                                                
                                                    - CBNumber:
 
                                                    - CB53311517
 
                                                 
                                                
                                                    - 分子式:
 
                                                    - C22H31N7O3SSi
 
                                                 
                                                
                                                    - 分子量:
 
                                                    - 501.68
 
                                                 
                                                
                                                    - MOL File:
 
                                                    - 1187594-13-3.mol
 
                                                 
                                             
                                            
                                         | 
                                     
                                 
                             | 
	 
 
                     |